Discover investment opportunities in Veterinary Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Veterinary Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Veterinary Stocks using our Smart AI Filter.
5 stocks found for "Veterinary Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.98 | ±24.4% | 25.1 | 1.27% | |||
0.49 | ±19.6% | 26.1 | 1.76% | |||
0.69 | ±39.1% | 11.8 | 0.00% | |||
0.00 | ±0.0% | 45.7 | 0.00% | |||
0.81 | ±44.0% | 9.0 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
Read moreInvestors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR (SDZNY) or Zoetis (ZTS). But which of these two companies is the best option for those looking for undervalued stocks?
Read moreThe headline numbers for Neogen (NEOG) give insight into how the company performed in the quarter ended May 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read moreQ: What factors might drive the growth potential of veterinary stocks like ZTS and IDXX?
A: Growth in veterinary stocks, such as Zoetis (ZTS) and IDEXX Laboratories (IDXX), can be driven by rising pet ownership trends, increased spending on pet healthcare, and advances in veterinary medical technology. Additionally, growth in emerging markets and innovations in animal diagnostics contribute to their potential.
Q: How do dividend prospects vary among veterinary stocks featured on this screener?
A: Dividend prospects can vary significantly. For instance, Zoetis (ZTS) has a history of dividend payments, which may appeal to income-focused investors. In contrast, some veterinary stocks, like IdiXX (IDXX), may prioritize reinvestment in growth over dividends, leading to different income strategies.
Q: What are some sector-specific risks associated with investing in veterinary stocks such as ELAN and PETQ?
A: Sector-specific risks include regulatory challenges, changes in consumer preferences, and competition from generic products. Additionally, veterinary pharmaceutical companies like Elanco (ELAN) and PetIQ (PETQ) may face risks related to supply chain disruptions and patent expirations.
Q: How might the economic cycle impact the performance of companies like MRNA in the veterinary sector?
A: While Moderna (MRNA) is primarily known for human vaccines, its expansion into veterinary vaccines could be impacted by economic cycles. During economic downturns, veterinary spending might decline as discretionary budgets tighten, potentially affecting revenue. However, essential pet care may remain stable.
Q: What competitive advantages might stocks like ZTS have within the veterinary pharmaceutical industry?
A: Zoetis (ZTS) holds competitive advantages due to its large product portfolio, established global distribution networks, and continued investment in R&D. Its focus on innovation and commitment to addressing diverse animal health needs solidify its leading position within the industry.
Q: Are veterinary stocks such as GENE considered good value investments?
A: Genetic Technologies (GENE) typically operates in niche markets within biotech, which may result in valuation complexities. Investors seeking value might analyze GENE's financial metrics, market position, and growth potential, although broader biotechnology sector trends should also be considered.